Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myasthenic syndrome

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 6, 2002, Pages 766-768

  Wirtz, P W ^a   Sotodeh, M ^a   Nijnuis, M ^a   Van Doorn, P A ^b   Van Engelen, B G M ^c   Hintzen, R Q ^b   De Kort, P L M ^d   Kuks, J B ^e   Twijnstra, A ^f   De Visser, M ^g   Visser, L H ^d   Wokke, J H ^h   Wintzen, A R ^a   Verschuuren, J J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CPRLab   (Netherlands)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARM; ARTICLE; BULBAR PARALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISEASE COURSE; DISEASE SEVERITY; DYSARTHRIA; DYSPHAGIA; EATON LAMBERT SYNDROME; EXTRAOCULAR MUSCLE; FEMALE; HUMAN; LEG MUSCLE; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PTOSIS;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MIDDLE AGED; MUSCLE WEAKNESS; NETHERLANDS; NEUROLOGIC EXAMINATION; OCULOMOTOR MUSCLES; RETROSPECTIVE STUDIES;

EID: 0036903006     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.6.766     Document Type: Article

References (11)

1. O'Neill JH, Murray NMF, Newsom-Davis J. The Lambert Eaton myasthenic syndrome. A review of 50 cases. Brain 1988;111:577-96.
2. Lambert EH, Rooke ED. Myasthenic state and lung cancer. In: Brain WR, Norris FH, eds. The Remote Effects of Cancer on the Nervous System. New York: Grune and Stratton, 1965:67-80.
3. Sanders DB. Lambert-Eaton myasthenic syndrome: Clinical diagnosis, immune-mediated mechanisms, and update on therapies. Ann Neurol 1995;37:S63-73.
4. Motomura M, Johnston I, Lang B, et al. An improved diagnostic assay for the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-7.
5. Grob D, Brunner NG, Namba T. The natural course of myasthenia gravis and effect of therapeutic measures. Ann NY Acad Sci 1981;377:652-69.
6. Beekman R, Kuks JBM, Oosterhuis HJGH. Myasthenia gravis: Diagnosis and follow-up of 100 consecutive patients. J Neurol 1997;244:112-18.
7. Robertson, NP, Deans J, Compston DAS. Myasthenia gravis: A population based epidemiological study in Cambridgeshire, England. J Neurol Neurosurg Psychiatry 1998;65:492-6.
8. Bever CT, Aquino AV, Penn AS, et al. Prognosis of ocular myasthenia. Ann Neurol 1983;14:516-19.
9. Oh SJ, Kuruoglu R. Chronic limb-girdle myasthenia gravis. Neurology 1992;42:1153-6.
10. Kaminski HJ, Maas E, Spiegel P, et al. Why are eye muscles frequently involved in myasthenia gravis? Neurology 1990;40:1663-9.
11. MacLennan C, Beeson D, Buijs AM, et al. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myosthenia gravis. Ann Neurol 1997;41:423-31.